ARMATA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 23.80 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 23.03K shares, a 87.36% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 769.00 shares, a 98.98% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 7.13K shares, a 97.19% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 81.63K shares, a 88.52% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 346.50K shares, a 71.85% decline from fiscal 2024.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.23M shares, a 138.41% increase from fiscal 2023.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 516.35K shares, a 89.08% increase from fiscal 2022.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 273.09K shares, a 1620.05% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 23.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 23.80K shares 10-Q · filed 2026-08-12 | 30.93K shares derived: sum of 3 quarters · filed 2026-08-12 | 112.55K shares derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | 769.00 shares 10-Q · filed 2026-05-13 | 7.89K shares derived: sum of 2 quarters · filed 2026-05-13 | 89.52K shares derived: sum of 3 quarters · filed 2026-05-13 | 271.77K shares derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-12-31 | 7.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 88.75K shares derived: sum of 2 quarters · filed 2026-03-25 | 271.00K shares derived: sum of 3 quarters · filed 2026-03-25 | 346.50K shares 10-K · filed 2026-03-25 | |
| 2025-09-30 | 81.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 263.88K shares derived: sum of 2 quarters · filed 2025-11-12 | 339.38K shares 10-Q · filed 2025-11-12 | 593.14K shares derived: sum of 4 quarters · filed 2025-11-12 | |
| 2025-06-30 | 182.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 257.75K shares 10-Q · filed 2025-08-12 | 511.52K shares derived: sum of 3 quarters · filed 2025-08-12 | 1.22M shares derived: sum of 4 quarters · filed 2025-08-12 | |
| 2025-03-31 | 75.50K shares 10-Q · filed 2025-05-14 | 329.27K shares derived: sum of 2 quarters · filed 2025-05-14 | 1.04M shares derived: sum of 3 quarters · filed 2025-05-14 | 1.25M shares derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-12-31 | 253.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 964.77K shares derived: sum of 2 quarters · filed 2025-03-21 | 1.17M shares derived: sum of 3 quarters · filed 2025-03-21 | 1.23M shares 10-K · filed 2025-03-21 | |
| 2024-09-30 | 711.01K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 916.01K shares derived: sum of 2 quarters · filed 2024-11-13 | 977.26K shares 10-Q · filed 2024-11-13 | 1.04M shares derived: sum of 4 quarters · filed 2024-11-13 | |
| 2024-06-30 | 205.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 266.25K shares 10-Q · filed 2024-08-13 | 327.10K shares derived: sum of 3 quarters · filed 2024-08-13 | 614.23K shares derived: sum of 4 quarters · filed 2024-08-13 | |
| 2024-03-31 | 61.24K shares 10-Q · filed 2024-05-07 | 122.09K shares derived: sum of 2 quarters · filed 2024-05-07 | 409.22K shares derived: sum of 3 quarters · filed 2024-05-07 | 572.72K shares derived: sum of 4 quarters · filed 2024-05-07 | |
| 2023-12-31 | 60.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 347.98K shares derived: sum of 2 quarters · filed 2024-03-21 | 511.48K shares derived: sum of 3 quarters · filed 2024-03-21 | 516.35K shares 10-K · filed 2024-03-21 | |
| 2023-09-30 | 287.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 450.63K shares derived: sum of 2 quarters · filed 2023-11-14 | 455.50K shares 10-Q · filed 2023-11-14 | 525.86K shares derived: sum of 4 quarters · filed 2023-11-14 | |
| 2023-06-30 | 163.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 168.37K shares 10-Q · filed 2023-08-14 | 238.73K shares derived: sum of 3 quarters · filed 2023-08-14 | 261.24K shares derived: sum of 4 quarters · filed 2023-08-14 | |
| 2023-03-31 | 4.87K shares 10-Q · filed 2023-05-11 | 75.23K shares derived: sum of 2 quarters · filed 2023-05-11 | 97.74K shares derived: sum of 3 quarters · filed 2023-05-11 | 174.62K shares derived: sum of 4 quarters · filed 2023-05-11 | |
| 2022-12-31 | 70.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 92.86K shares derived: sum of 2 quarters · filed 2023-03-16 | 169.75K shares derived: sum of 3 quarters · filed 2023-03-16 | 273.09K shares 10-K · filed 2023-03-16 | |
| 2022-09-30 | 22.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 99.39K shares derived: sum of 2 quarters · filed 2022-11-09 | 202.73K shares 10-Q · filed 2022-11-09 | 206.70K shares derived: sum of 4 quarters · filed 2022-11-09 | |
| 2022-06-30 | 76.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 180.23K shares 10-Q · filed 2022-08-11 | 184.20K shares derived: sum of 3 quarters · filed 2022-08-11 | 188.63K shares derived: sum of 4 quarters · filed 2022-08-11 | |
| 2022-03-31 | 103.34K shares 10-Q · filed 2022-05-12 | 107.31K shares derived: sum of 2 quarters · filed 2022-05-12 | 111.75K shares derived: sum of 3 quarters · filed 2022-05-12 | 113.62K shares derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-12-31 | 3.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 8.40K shares derived: sum of 2 quarters · filed 2022-03-17 | 10.28K shares derived: sum of 3 quarters · filed 2022-03-17 | 15.88K shares 10-K · filed 2022-03-17 | |
| 2021-09-30 | 4.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 6.31K shares derived: sum of 2 quarters · filed 2021-11-10 | 11.91K shares 10-Q · filed 2021-11-10 | 40.30K shares derived: sum of 4 quarters · filed 2021-11-10 | |
| 2021-06-30 | 1.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 7.47K shares 10-Q · filed 2021-08-12 | 35.86K shares derived: sum of 3 quarters · filed 2021-08-12 | 96.28K shares derived: sum of 4 quarters · filed 2021-08-12 | |
| 2021-03-31 | 5.60K shares 10-Q · filed 2021-05-13 | 33.99K shares derived: sum of 2 quarters · filed 2021-05-13 | 94.41K shares derived: sum of 3 quarters · filed 2021-05-13 | 97.06K shares derived: sum of 4 quarters · filed 2021-05-13 | |
| 2020-12-31 | 28.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 88.81K shares derived: sum of 2 quarters · filed 2021-03-18 | 91.46K shares derived: sum of 3 quarters · filed 2021-03-18 | 130.84K shares 10-K · filed 2021-03-18 | |
| 2020-09-30 | 60.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 63.07K shares derived: sum of 2 quarters · filed 2020-11-12 | 102.45K shares 10-Q · filed 2020-11-12 | 165.95K shares derived: sum of 4 quarters · filed 2020-11-12 | |
| 2020-06-30 | 2.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 42.03K shares 10-Q · filed 2020-08-13 | 105.53K shares derived: sum of 3 quarters · filed 2020-08-13 | 162.55K shares derived: sum of 4 quarters · filed 2020-08-13 | |
| 2020-03-31 | 39.38K shares 10-Q · filed 2020-05-14 | 102.88K shares derived: sum of 2 quarters · filed 2020-05-14 | 159.90K shares derived: sum of 3 quarters · filed 2020-05-14 | -125.90K shares derived: sum of 4 quarters · filed 2020-05-14 | |
| 2019-12-31 | 63.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | 120.52K shares derived: sum of 2 quarters · filed 2020-03-19 | -165.28K shares derived: sum of 3 quarters · filed 2020-03-19 | 120.89K shares 10-K · filed 2020-03-19 | |
| 2019-09-30 | 57.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -228.78K shares derived: sum of 2 quarters · filed 2019-11-12 | 57.39K shares 10-Q · filed 2019-11-12 | 57.49K shares derived: sum of 4 quarters · filed 2019-11-12 | |
| 2019-06-30 | -285.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 374.00 shares 10-Q · filed 2019-08-14 | 473.00 shares derived: sum of 3 quarters · filed 2019-08-14 | 2.22K shares derived: sum of 4 quarters · filed 2019-08-14 | |
| 2019-03-31 | 286.17K shares 10-Q · filed 2019-05-06 | 286.27K shares derived: sum of 2 quarters · filed 2019-05-06 | 288.02K shares derived: sum of 3 quarters · filed 2019-05-06 | 288.15K shares derived: sum of 4 quarters · filed 2019-05-06 | |
| 2018-12-31 | 99.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | 1.85K shares derived: sum of 2 quarters · filed 2019-03-25 | 1.98K shares derived: sum of 3 quarters · filed 2019-03-25 | 3.30K shares 10-K · filed 2019-03-25 | |
| 2018-09-30 | 1.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 1.88K shares derived: sum of 2 quarters · filed 2018-11-08 | 3.20K shares 10-Q · filed 2018-11-08 | 4.10K shares derived: sum of 4 quarters · filed 2019-03-25 | |
| 2018-06-30 | 128.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 1.45K shares 10-Q · filed 2018-08-09 | 2.35K shares derived: sum of 3 quarters · filed 2019-03-25 | 2.35K shares derived: sum of 4 quarters · filed 2019-03-25 | |
| 2018-03-31 | 1.32K shares 10-Q · filed 2018-05-15 | 2.22K shares derived: sum of 2 quarters · filed 2019-03-25 | 2.22K shares derived: sum of 3 quarters · filed 2019-03-25 | 29.66K shares derived: sum of 4 quarters · filed 2019-03-25 | |
| 2017-12-31 | 900.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | 900.00 shares derived: sum of 2 quarters · filed 2019-03-25 | 28.34K shares derived: sum of 3 quarters · filed 2019-03-25 | 29.60K shares 10-K · filed 2019-03-25 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 27.43K shares derived: sum of 2 quarters · filed 2017-11-14 | 28.70K shares 10-Q · filed 2017-11-14 | -111.67K shares derived: sum of 4 quarters · filed 2018-03-14 | |
| 2017-06-30 | 27.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 28.70K shares 10-Q · filed 2017-08-14 | -111.67K shares derived: sum of 3 quarters · filed 2018-03-14 | -103.67K shares derived: sum of 4 quarters · filed 2018-03-14 | |
| 2017-03-31 | 1.26K shares 10-Q · filed 2017-05-15 | -139.10K shares derived: sum of 2 quarters · filed 2018-03-14 | -131.10K shares derived: sum of 3 quarters · filed 2018-03-14 | ||
| 2016-12-31 | -140.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -132.36K shares derived: sum of 2 quarters · filed 2018-03-14 | 18.49K shares 10-K · filed 2018-03-14 | 185.04K shares 10-K · filed 2017-03-27 | |
| 2016-09-30 | 8.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 158.86K shares 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | 150.86K shares 10-Q · filed 2016-08-15 | ||||
| 2015-12-31 | 147.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | 152.68K shares 10-K · filed 2017-03-27 | 4.81K shares 10-K · filed 2016-03-30 | ||
| 2015-09-30 | 4.81K shares 10-Q · filed 2015-11-16 | ||||
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |